SCHEMBL10256504

SCHEMBL10256504

O=C(O)[S+]([O-])Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.50
CES2 O00748 1/20 0.50
AKR1B1 P15121 1/20 0.44
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
KEAP1 Q14145 1/20 0.41
CYP1A2 P05177 1/20 0.40
HDAC8 Q9BY41 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetone SCHEMBL26919912 0.76 CES2 (0.48) CES1CES2AKR1B1FNTAFNTB
SCHEMBL29131299 0.74 CYP1A2 (0.47) CES1CES2AKR1B1FNTAFNTB
SCHEMBL9640656 0.74 CES2 (0.46) CES1CES2AKR1B1FNTAFNTB
SCHEMBL3236978 0.74 CES2 (0.46) CES1CES2AKR1B1FNTAFNTB
SCHEMBL29131301 0.74 CYP1A2 (0.47) CES1CES2AKR1B1FNTAFNTB
SCHEMBL10804715 0.72 CYP1A2 (0.45) CES1CES2AKR1B1CYP1A2ALDH1A1
SCHEMBL7195427 0.72 CES1 (0.56) CES1CES2AKR1B1FNTAFNTB
Benzene SCHEMBL11030926 0.72 CALM1 (0.45) CES1CES2ALDH1A1SMN1; SMN2TSHR
SCHEMBL340372 0.72 CALM1 (0.45) CES1CES2ALDH1A1SMN1; SMN2TSHR
SCHEMBL29131294 0.71 CES2 (0.43) CES1CES2AKR1B1FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101800-B2 5,6-dihydro-1H-pyridin-2-one compounds ANADYS PHARMACEUTICALS, INC. (US) 2012-01-24 US disclosed
US-20110166344-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166344-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS DPYD, NQO1, MT-ND5 CES1 2422/4885CES2 1981/4885AKR1B1 419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.